Professor David Kiely

Journal articles

Chapters

  • Condliffe RA, Elliot CA & Kiely DG (2009) Deep Vein Thrombosis and Pulmonary Embolism In Beek EJRV, Büller HR & Oudkerk M (Ed.), Deep Vein Thrombosis and Pulmonary Embolism (pp. 405-420). Wiley
  • Kiely DG, Elliot CA, Webster VJ & Stewart P (2006) Heart Disease and Pregnancy In Steer PJ, Gatzoulis MA & Baker P (Ed.), Heart Disease and Pregnancy (pp. 211-229). Rcog

Conference proceedings papers

  • Hawes R, Wilson V, Newton R, Ten Klooster L, Kiely D, Condliffe R, Elliot C & Gandhi S (2017) Safe delivery of parturients with pulmonary hypertension: 16 years' experience in a national specialist referral centre. ANAESTHESIA, Vol. 72 (pp 56-56)
  • Lungu A, Hose DR, Kiely DG, Capener D, Wild JM & Swift AJ (2017) Three element windkessel model to non-invasively assess PAH patients: One year follow-up. IFMBE Proceedings, Vol. 59 (pp 151-154)
  • Johns CS, Capener D, Hammerton C, Shotton K, Kiely DG, Wild JM & Swift AJ (2016) P45 Non-invasive methods for the estimation of mpap in COPD patients using cardiac mri. Thorax, Vol. 71(Suppl 3) (pp A106-A107)
  • Hadinnapola C, Haimel M, Bleda M, Bogaard H, Coghlan G, Corris P, Gibbs S, Kiely D, Lawrie A, Peacock A, Pepke-Zaba J, Southgate L, Toshner M, Trembath R, Noordegraaf AV, Wharton J, Wilkins M, Wort SJ, Graf S & Morrell NM (2016) S107 Genotype-phenotype associations in pulmonary arterial hypertension caused by BMPR2 and EIF2AK4 variants. Thorax, Vol. 71(Suppl 3) (pp A63-A64)
  • Ramjug S, Hussain N, Hurdman J, Billings C, Elliot CA, Kiely DG, Sabroe I, Rajaram S, Swift AJ & Condliffe R (2016) S111 Differences in characteristics and outcomes in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. Thorax, Vol. 71(Suppl 3) (pp A66-A67)
  • Quadery SR, Condliffe RA, Billings C, Thompson R, Elliot CA, Charalampopolous A, Hurdman J, Hamilton N, Armstrong I, Sephton P, Sabroe I, Swift A, Wild J & Kiely DG (2016) P28 Chronic thromboembolic pulmonary hypertension: long term outcomes in surgical and non-surgical patients. Thorax, Vol. 71(Suppl 3) (pp A98.1-A98)
  • Lin J, Iremonger J, Pickworth J, Rothman A, Casbolt H, Arnold N, Elliot C, Condliffe R, Kiely D & Lawrie A (2016) P245 Whole blood levels of microrna-34a predict survival and regulate genes associated with pulmonary arterial hypertension. Thorax, Vol. 71(Suppl 3) (pp A220.2-A221)
  • Thompson AAR, Arnold ND, Braithwaite AT, Casbolt HL, Pickworth JA, Cole JE, Monaco C, Kiely D, Sabroe I & Lawrie A (2016) Deficiency Of Toll-Like Receptor 3 (TLR3) Exacerbates Pulmonary Hypertension In Mice (pp A3055-A3055)
  • Smith I, Billings C, Kiely D, Yorke J & Armstrong I (2016) Extended Evaluation Of Emphasis-10 Quality Of Life Questionnaire In Ph. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
  • Toshner M, Bleda M, Newnham M, Lang I, Delcroix M, Cannon J, Sheares K, Coghlan G, Corris PA, Gibbs S, Kiely D, Peacock A, Simpson M, Trembath RC, Wilkins MR, Wort S, Ng C, Dunning J, Screaton N, Tsui S, Jenkins D, Graf S, Pepke-Zaba J & Morrell NW (2016) Genome Wide Association Studies In Chronic Thromboembolic Pulmonary Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
  • Iremonger J, Rothman AM, Rhodes C, Condliffe R, Elliot CA, Kiely D, Howard LS, Gibbs S, Wharton J, Wilkins MR & Lawrie A (2016) Investigating The Diagnostic Potential Of Circulating Mirna Signatures In Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
  • Rhodes C, Wharton J, Ghataorhe P, Watson G, Girerd B, Howard LS, Gibbs S, Condliffe R, Elliot CA, Kiely D, Simonneau G, Montani D, Sitbon O, Gall H, Schermuly RT, Ghofrani H, Lawrie A, Humbert M & Wilkins M (2016) Plasma Proteome Analysis In Idiopathic Pulmonary Arterial Hypertension Identifies A Panel Of Prognostic Proteins. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
  • Treacy C, Blenda M, Hadinnapola C, Haimel M, Coghlan G, Corris PA, Gibbs JS, Kiely DG, Lawrie A, Peacock AJ, Pepke-Zaba J, Trembath RC, Wharton J, Wilkins MR, Wort S, Graf S, Morrell NW & Study UKNPAHC (2016) The Uk National Cohort Study Of Idiopathic And Heritable Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
  • Hadinnapola C, Bleda M, Haimel M, Bogaard HJ, Coghlan G, Corris PA, Gibbs JS, Kiely DG, Lawrie A, Peacock AJ, Machado RD, Pepke-Zaba J, Vonk-Noordegraaf A, Trembath RC, Wharton J, Wilkins MR, Wort S, Graf S, Morrell NW, NIHR B-RDBP & Consortiu UKNPAHCS (2016) Utility Of Deep Phenotyping In The Identification And Validation Of Novel Causal Whole Genome Sequencing Variation In Patients With Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
  • Graf S, Bleda M, Hadinnapola C, Haimel M, Bogaard HJ, Coghlan G, Corris PA, Gibbs JS, Kiely DG, Lawrie A, Machado RD, Peacock AJ, Pepke-Zaba J, Trembath RC, Vonk-Noordegraaf A, Wharton J, Wilkins MR, Wort S, Morrell NW & BRIDGE NB-RD (2016) Whole Genome Sequencing In Idiopathic And Heritable Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 193
  • Carter S, Jutley G, Kiely D, Condliffe R, Renshaw S, Whyte M, Kuet K, Kilding R & Akil M (2015) SAT0477 Rituximab Treatment for Connective Tissue Disease Associated Interstitial Lung Disease: A Retrospective Case Series. Annals of the Rheumatic Diseases, Vol. 74(Suppl 2) (pp 833.1-833)
  • Billings C, Hurdman J, Condliffe R, Armstrong I, Smith I, Elliot C & Kiely D (2014) S121 The Utility Of The Incremental Shuttle Walking Test In Pulmonary Hypertension: Results From The Aspire Registry. Thorax, Vol. 69(Suppl 2) (pp A65-A65)
  • Swift A, Rajaram S, Capener D, Elliot C, Condliffe R, Hurdman J, Kiely D & Wild J (2014) S120 Right Ventricular Dysfunction In Pulmonary Hypertension With Combined Pulmonary Fibrosis And Emphysema Syndrome. Thorax, Vol. 69(Suppl 2) (pp A64-A65)
  • Hussain N, Ramjug S, Billings C, Hurdman J, Elliot C, Condliffe R & Kiely D (2014) P168 Reduced Gas Transfer (tlco) Predicts Poor Outcome In Patients With Pulmonary Hypertension And Heart Failure With Preserved Ejection Fraction. Thorax, Vol. 69(Suppl 2) (pp A148-A148)
  • De Foneska D, Condliffe R, Elliot C, Hughes R, Hurdman J, Ghafur S, Schofield M, van Veen J, Maclean R & Kiely D (2014) S118 Incidence And Severity Of Chronic Thromboembolic Pulmonary Hypertension Following The Introduction Of A One-stop Clinic For Acute Pulmonary Embolism. Thorax, Vol. 69(Suppl 2) (pp A63-A64)
  • Billings C, Hurdman J, Austin M, Armstrong I, Elliot C, Condliffe R & Kiely D (2014) P170 Heart Rate Recovery At One Minute Following Incremental Shuttle Walk Test Predicts Outcome In Pulmonary Hypertension. Thorax, Vol. 69(Suppl 2) (pp A148-A149)
  • Stewart N, Norquay G, Parra-Robles J, Marshall H, Leung G, Murphy P, Schulte R, Elliot C, Condliffe R, Billings C, Smith I, Griffiths P, Wolber J, Whyte M, Kiely D & Wild J (2014) P273 Assessment Of Lung Microstructure In Interstitial Lung Disease With Hyperpolarised Gas Mri. Thorax, Vol. 69(Suppl 2) (pp A192-A193)
  • Stewart NJ, Leung G, Norquay G, Marshall H, Parra-Robles J, Billings C, Murphy P, Schulte RF, Wolber J, Kiely DG, Whyte MKB & Wild JM (2014) Age-dependent changes in whole-lung septal thickness measured by Xe-129 MRI: A comparison of healthy volunteers and subjects with IPF. EUROPEAN RESPIRATORY JOURNAL, Vol. 44
  • Stewart NJ, Leung G, Norquay G, Marshall H, Parra-Robles J, Billings C, Murphy P, Schulte RF, Wolber J, Kiely DG, Whyte MKB & Wild JM (2014) Age-dependent changes in whole-lung septal thickness measured by Xe-129 MRI: A comparison of healthy volunteers and subjects with IPF. EUROPEAN RESPIRATORY JOURNAL, Vol. 44
  • Sithamparanathan S, Thirugnanasothy L, Nair A, Goghlan G, Elliot C, Fisher A, Gaine S, Gibbs S, Gatzoulis M, Handler C, Howard L, Johnson M, Kiely D, Lordan J, Peacock A, Pepke-Zaba J, Sabroe I, Sheares K, Vvort S & Corris P (2014) Portopulmonary hypertension in United Kingdom; A contemporary, national, observational study. EUROPEAN RESPIRATORY JOURNAL, Vol. 44
  • Arnold N, Dawson S, Chang W, Suvarna K, Kiely D, Gunn J, Lawrie A & Rothman AMK (2014) Radio-Frequency Denervation Of The Pulmonary Artery Reduces Pulmonary Hypertension In An Acute Porcine Model. Am J Respir Crit Care Med, Vol. 189 (pp A5567)
  • Lungu A, Wild J, Swift A, Capener D, Kiely D & Hose DR (2014) Automatic, simultaneous, Non - Invasive measurements of flow and area in the human pulmonary arteries from MRI images. IFMBE Proceedings, Vol. 44 (pp 259-264)
  • Condliffe R, Elliot CA, Sabroe I, Zamanian RT, Morton A, Swift AJ, Kiely DG & Lawrie A (2013) HEPATOCYTE GROWTH FACTOR CONCENTRATION CORRELATES WITH HAEMODYNAMIC SEVERITY IN CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION. THORAX, Vol. 68 (pp A146-A147)
  • Hameed AG, Arnold ND, Chamberlain J, Pickworth JA, Paiva C, Dawson S, Cross S, Long L, Zhao L, Morrell NW, Crossman DC, Newman CMH, Kiely DG, Francis SE & Lawrie A (2013) Tumour necrosis factor-related apoptosis-inducing ligand is a novel therapeutic target in pulmonary arterial hypertension. The Lancet, Vol. 381, Supplement 1 (pp S47 --S47 -)
  • Condliffe R, Pickworth J, Hopkinson K, Hameed A, Walker S, Elliot C, Francis S, Newman C, Crossman D, Morton A, Kiely D & Lawrie A (2011) SERUM OSTEOPROTEGERIN PREDICTS MORTALITY IN A PROSPECTIVE STUDY ON INCIDENT CASES OF PULMONARY ARTERIAL HYPERTENSION. THORAX, Vol. 66 (pp A34-A34)
  • Ling Y, Johnson MK, Kiely D, Condliffe R, Elliot C, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P, Fisher A, Lordan J, Gaine S, Coghlan G, Wort J, Gatzoulis M & Peacock AJ (2011) PREDICTION OF SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION USING SURVIVAL EQUATIONS. RESULTS FROM THE PULMONARY HYPERTENSION REGISTRY OF THE UK AND IRELAND. THORAX, Vol. 66 (pp A35-A36)
  • Ling Y, Johnson MK, Kiely D, Condliffe R, Elliot C, Gibbs S, Howard L, Pepke-Zaba J, Sheares K, Corris P, Fisher A, Lordan J, Gaine S, Coghlan G, Wort J, Gatzoulis M & Peacock AJ (2011) INFLUENCE OF AGE ON CLINICAL PHENOTYPES OF INCIDENT IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION. RESULTS FROM THE PULMONARY HYPERTENSION REGISTRY OF THE UK AND IRELAND. THORAX, Vol. 66 (pp A34-A35)
  • Swift AJ, Rajaram S, Condliffe R, Capener D, Hill C, Davies C, Hurdman J, Elliot C, Wild JM & Kiely DG (2011) DIAGNOSTIC UTILITY AND PROGNOSTIC VALUE OF QUANTITATIVE CARDIAC MR INDICES IN PATIENTS WITH SUSPECTED PULMONARY HYPERTENSION. THORAX, Vol. 66 (pp A34-A34)
  • Rajaram S, Swift AJ, Capener D, Hill C, Davies C, Elliot R, Hurdman J, Condliffe R, Wild JM & Kiely DG (2011) ACCURACY OF CONTRAST ENHANCED MR LUNG PERFUSION COMPARED TO PERFUSION SCINTIGRAPHY IN DIAGNOSING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION. THORAX, Vol. 66 (pp A13-A14)
  • Hurdman J, Condliffe RA, Elliot CA, Sabroe I & Kiely DG (2010) PULMONARY HYPERTENSION (PH) ASSOCIATED WITH LUNG DISEASE/HYPOXIA. THORAX, Vol. 65 (pp A93-A93)
  • Shepherd AJ, Hopkinson K, Kiely DG, Elliot CE, Condliffe R, Crossman DC, Pockley AG & Lawrie A (2010) CHARACTERISING T CELL SUB-POPULATIONS IN PULMONARY HYPERTENSION. THORAX, Vol. 65 (pp A91-A91)
  • Condliffe R, Billings C, Elliot CA, Smith I, Armstrong IJ, Smith L & Kiely DG (2008) INCREMENTAL SHUTTLE AND 6-MINUTE WALK TESTS: CORRELATIONS WITH PULMONARY HAEMODYNAMICS AND CARDIOPULMONARY EXERCISE TESTING IN PULMONARY HYPERTENSION. THORAX, Vol. 63 (pp A55-A55)
  • Wilkinson A, Elliot CA, Mawson S, Armstrong I, Billings C & Kiely DG (2007) A randomised controlled trial to investigate the effects of a physiotherapist-led rehabilitation programme on exercise capacity and quality of life measures in patients with pulmonary hypertension. THORAX, Vol. 62 (pp A16-A17)
  • Hagger D, Woodhouse N, Elliot CA, Wild J, Armstrong I, Hill C, Davies C & Kiely DG (2007) Ventricular mass index measured using magnetic resonance imaging correlates with pulmonary artery pressure in patients with systemic sclerosis and suspected pulmonary arterial hypertension. THORAX, Vol. 62 (pp A84-A84)
  • Elliot CA, Billings C, Armstrong I, Waterhouse J, Billings C, Akil M & Kiely DG (2007) Reduced incremental shuttle walking test distance is associated with a worse survival in pulmonary arterial hypertension associated with systemic sclerosis. THORAX, Vol. 62 (pp A85-A85)
  • Beghetti M, Hoeper MM, Kiely DG, Carlsen J, Segal E & Humbert M (2006) Long-term safety profile of bosentan in paediatric patients with pulmonary arterial hypertension related to congenital heart defects or other aetiologies. EUROPEAN HEART JOURNAL, Vol. 27 (pp 401-401)
  • Denton CP, Coghlan J, Black CM, Hoeper MM, Kiely DG, Carlsen J, Segal E & Humbert M (2006) Long-term safety profile of bosentan in patients with pulmonary arterial hypertension related to mixed connective tissue disease or systemic lupus erythematosus: Results from the Tracleer post marketing surveillance database. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 389-389)
  • Anwar S, Elliot CA, English K, Williams G, Brooks N, O'Toole L, Armstrong IJ, Hamilton N, Saba TS & Kiely DG (2005) Treatment of pulmonary arterial hypertension in association with systemic to pulmonary shunts: A retrospective review. THORAX, Vol. 60 (pp II89-II89)
  • Elliot CA, Wright J, Ryan K, Woodhead M, Armstrong IJ, Saba TS & Kiely DG (2005) Haemolytic disorders complicated by pulmonary hypertension. THORAX, Vol. 60 (pp II87-II88)
  • Kiely DG, Carlsen J, Humbert M, van Lierop C & Hoeper MM (2005) Long term experience with bosentan for the treatment of idiopathic pulmonary arterial hypertension under routine conditions. THORAX, Vol. 60 (pp II88-II89)
  • Billings CG, Elliot CA, Armstrong IJ, Saba TS & Kiely DG (2005) Abnormal post-exercise systolic blood pressure response to exercise is common in patients with suspected pulmonary hypertension. THORAX, Vol. 60 (pp II88-II88)
  • Carlsen J, Hoeper MM, Kiely DG, van Lierop C & Humbert M (2005) Long-term safety profile of bosentan in patients with chronic thromboembolic pulmonary hypertension (CTEPH): results from the TRAX database. EUROPEAN HEART JOURNAL, Vol. 26 (pp 113-113)
  • Carlsen J, Humbert M, Kiely DG, van Lierop C, Schwierin B & Hoeper MM (2005) Clinical experience with bosentan for the treatment of pulmonary hypertension associated with congenital heart disease. EUROPEAN HEART JOURNAL, Vol. 26 (pp 215-216)
  • Denton CP, Coghlan J, Black CM, Hoeper MM, Kiely DG, Carlsen J, Van Lierop C & Humbert M (2005) Long-term safety profile of bosentan in patients with systemic sclerosis and pulmonary arterial hypertension: Results from the TRAX database. ANNALS OF THE RHEUMATIC DISEASES, Vol. 64 (pp 294-294)
  • Elliot CA, Wright J, Ryan K, Woodhead M, Armstrong IJ, Saba TS & Kiely DG (2005) Pulmonary hypertension as a complication of haemolysis. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 129 (pp 47-47)
  • MacDonald IM, Woodhouse N, Elliot C, Armstrong I, Kiely DG, Marshall G & Van Beek EJR (2004) Increased pulmonary artery to aortic ratio measured using magnetic resonance imaging identifies patients with pulmonary hypertension. THORAX, Vol. 59(1) (pp 8-8)
  • Elliot CA, Webster V, Stewart P, Barraclough RM, Mills G, Hutkchinson S, Haworth E, Lawson R, Armstrong IJ & Kiely DG (2004) Use of nebulised iloprost therapy in early pregnancy in patients with pulmonary hypertension. THORAX, Vol. 59(1) (pp 86-86)
  • Elliot CA, Armstrong IJ, Billings C, Waterhouse J, Hamilton N, Saba T & Kiely DG (2004) Incremental shuttle walking test distance predicts prognosis in patients with pulmonary hypertension treated with targeted pulmonary vascular therapy. THORAX, Vol. 59(1) (pp 85-85)
  • van Veen J, Elliot CA, Martin L, Armstrong I, Kiely DG, Bowyer AE & Makris M (2004) Elevated factor VIII : C levels in patients with pulmonary hypertension. A marker of endothelial dysfunction?. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 125 (pp 46-46)
  • Elliot CA, Martin L, Armstrong I, Kiely DG, Bowyer AE & Makris M (2003) Elevated factor FVIII: C levels as a marker of endothelial dysfunction in patients with pulmonary hypertension. THORAX, Vol. 58 (pp 9-9)
  • Elliot CA, Armstrong I, Guarasci F, Akil M & Kiely DG (2003) Identification of patients with systemic sclerosis and pulmonary hypertension on exercise using a simple screening protocol. THORAX, Vol. 58 (pp 83-83)
  • Siddons T, Higenbottam TW, Guarasci F, Armstrong I, McCormack K & Kiely DG (2002) The haemodynamic effects of "pulsed" inhaled nitric oxide in patients with pulmonary hypertension. THORAX, Vol. 57
  • Siddons T, Higenbottam TW, Amsha K, Armstrong I, McCormack K & Kiely DG (2002) Compassionate treatment of pulmonary hypertension with long term inhaled nitric oxide and oral sildenafil (Viagra((R))). THORAX, Vol. 57
  • Guarasci F, Manuel D, Akil M, Davies C, Fishwick D, Van Beek EJR & Kiely DG (2002) Elevated pulmonary: Aortic ratio in patients with pulmonary arterial hypertension associated with systemic sclerosis. THORAX, Vol. 57
  • Lee AFC, Kiely DG, Coutie W & Struthers AD (1996) The renin response to frusemide in man is nitric oxide-dependent. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Vol. 42(5) (pp P652-P652)